New breathing technique could help obese heart surgery patients avoid ICU complications

NCT ID NCT07409324

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a specific ventilator mode called APRV can improve breathing and oxygen levels in very obese patients after elective heart surgery. 180 adults with a BMI of 40 or higher (or 35 with related health issues) will be randomly assigned to receive either APRV or standard ventilation after surgery. The goal is to see if APRV leads to better lung function, fewer breathing problems, and shorter ICU stays.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Airway Pressure Release Ventilation (APRV) - a mode on a mechanical ventilator

What this could lead to

If it works, this could lead to a standard way to help very obese patients breathe easier after heart surgery, potentially reducing ICU stays and breathing complications.

What could go wrong

This is an early-stage study (not yet recruiting) with only 180 patients, so results may not apply to everyone. The intervention is a device mode, not a drug, so benefits may be modest and risks include ventilator-related lung injury or discomfort.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTOPERATIVE RESPIRATORY DYSFUNCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

morbid obesity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••